Form SC 14D9 - Solicitation, recommendation statements:
SEC Accession No. 0001193125-26-280275
Filing Date
2026-06-24
Accepted
2026-06-24 08:02:34
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 14D9 d26485dsc14d9.htm SC 14D9 579330
2 GRAPHIC g26485g41g41.jpg GRAPHIC 27913
3 GRAPHIC g26485g45g45.jpg GRAPHIC 31193
  Complete submission text file 0001193125-26-280275.txt   656644
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filed by) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Subject) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9 | Act: 34 | File No.: 005-92743 | Film No.: 261113133
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)